APA (7th ed.) Citation

B, J., O, B., M, F., LC, H., A, K., M, T., . . . F, G. (2024). Intracranial response to capmatinib after progression on crizotinib in a patient with MET exon 14 skipping non-small cell lung cancer-a case report. Translational lung cancer research, 13(7), 1749. https://doi.org/10.21037/tlcr-23-769

Chicago Style (17th ed.) Citation

B, Jóri, Bundschuh O, Falk M, Heukamp LC, Kluge A, Tiemann M, Willborn KC, Woitzik J, and Griesinger F. "Intracranial Response to Capmatinib After Progression on Crizotinib in a Patient with MET Exon 14 Skipping Non-small Cell Lung Cancer-a Case Report." Translational Lung Cancer Research 13, no. 7 (2024): 1749. https://doi.org/10.21037/tlcr-23-769.

MLA (9th ed.) Citation

B, Jóri, et al. "Intracranial Response to Capmatinib After Progression on Crizotinib in a Patient with MET Exon 14 Skipping Non-small Cell Lung Cancer-a Case Report." Translational Lung Cancer Research, vol. 13, no. 7, 2024, p. 1749, https://doi.org/10.21037/tlcr-23-769.